Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2

We present a case of symptomatic heterotopic bone formation following revision of posterolateral lumbar fusion/instrumentation and “off-label” use of recombinant human bone morphogenetic protein-2, treated successfully with the use of a minimally invasive tubular approach.

Detalles Bibliográficos
Autores principales: Roberti, Fabio, Arsenault, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202823/
https://www.ncbi.nlm.nih.gov/pubmed/32387785
http://dx.doi.org/10.1016/j.wneu.2020.04.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202823/
https://www.ncbi.nlm.nih.gov/pubmed/32387785
http://dx.doi.org/10.1016/j.wneu.2020.04.235

Ejemplares similares